J. Vermylen
- Hematology top 5%
- Pulmonary and Respiratory Medicine top 10%
- Surgery
- Cardiology and Cardiovascular Medicine top 10%
- Cancer Research top 10%
- Co-authors
- H. ClaeysHans DeckmynMarc VerstraeteMaria Benedetta DonatiJ VandenbrouckeC. VermylenDaniël BlockmansM Verstraete
- Topics
- Antiplatelet Therapy and Cardiovascular Diseases (12 papers)Blood properties and coagulation (11 papers)Platelet Disorders and Treatments (9 papers)
- Partner nations
- BelgiumItalyUnited Kingdom
In The Last Decade
J. Vermylen
57 papers receiving 847 citations
Peers
Comparison fields: 5 of 88
- Hematology 336
- Pulmonary and Respiratory Medicine 223
- Surgery 195
- Cardiology and Cardiovascular Medicine 183
- Cancer Research 175
Countries citing papers authored by J. Vermylen
This map shows the geographic impact of J. Vermylen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Vermylen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Vermylen more than expected).
Fields of papers citing papers by J. Vermylen
This network shows the impact of papers produced by J. Vermylen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Vermylen. The network helps show where J. Vermylen may publish in the future.
Co-authorship network of co-authors of J. Vermylen
This figure shows the co-authorship network connecting the top 25 collaborators of J. Vermylen. A scholar is included among the top collaborators of J. Vermylen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Vermylen. J. Vermylen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 37 | |
| 2 | 11 | |
| 3 | Reversible hypoprothrombinemia in a patient with primary biliary cirrhosis treated with rifampicin. | 6 |
| 4 | 25 | |
| 5 | 32 | |
| 6 | 18 | |
| 7 | 7 | |
| 8 | 4 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | Thromboxane A2 and prostacyclin do not modulate the systemic hemodynamic response to cold in humans. | 5 |
| 12 | Acute effect of cigarette smoking on cardiac prostaglandin synthesis and platelet behavior in patients with coronary heart disease. | 7 |
| 13 | 1 | |
| 14 | 8 | |
| 15 | 4 | |
| 16 | 15 | |
| 17 | 1 | |
| 18 | Effects of suprofen, an inhibitor of prostaglandin biosynthesis, on platelet function, plasma coagulation and fibrinolysis II. In vivo experiments. | 18 |
| 19 | 10 | |
| 20 | 105 |
About J. Vermylen
J. Vermylen is a scholar working on Hematology, Internal Medicine and Biotechnology, having authored 59 papers that have together received 983 indexed citations. Recurring topics across this work include Antiplatelet Therapy and Cardiovascular Diseases (12 papers), Blood properties and coagulation (11 papers) and Platelet Disorders and Treatments (9 papers). The work is most often cited by research in Hematology (336 citations), Internal Medicine (102 citations) and Cancer Research (175 citations). J. Vermylen has collaborated with scholars based in Belgium, Italy and United Kingdom. Frequent co-authors include H. Claeys, Hans Deckmyn, Marc Verstraete, Maria Benedetta Donati, J Vandenbroucke, C. Vermylen, Daniël Blockmans, M Verstraete, Dalton A. F. Chamone and Bernard Spitz. Their work appears in journals such as The Lancet, Journal of Clinical Investigation and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.